Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Geers, DarylSablerolles, Roos S G
van Baarle, Debbie
Kootstra, Neeltje A
Rietdijk, Wim J R
Schmitz, Katharina S
Gommers, Lennert
Bogers, Susanne
Nieuwkoop, Nella J
van Dijk, Laura L A
van Haren, Eva
Lafeber, Melvin
Dalm, Virgil A S H
Goorhuis, Abraham
Postma, Douwe F
Visser, Leo G
Huckriede, Anke L W
Sette, Alessandro
Grifoni, Alba
de Swart, Rik L
Koopmans, Marion P G
van der Kuy, P Hugo M
GeurtsvanKessel, Corine H
de Vries, Rory D
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.Published in
iScience 2022;26(1):105753PMID
36507223ae974a485f413a2113503eed53cd6c53
10.1016/j.isci.2022.105753
Scopus Count
Collections